長江健康(002435.SZ):股東楊樹恆康和中山鬆德的減持計劃時間已過半
格隆匯 12 月 24日丨長江健康(002435.SZ)公佈,現公司收到股東楊樹恆康和中山鬆德出具的《股份減持進展告知函》,截至2020年12月24日,此次減持計劃時間已過半。
2020年12月18日,楊樹恆康簽署了《股份轉讓協議》,擬將其持有的本公司無限售流通股4025.5009萬股轉讓給蘇州蘇上健康產業投資合夥企業(有限合夥),佔公司總股本的3.25%(此處持股比例按照去尾數進行處理),詳見公司於2020年12月21日披露的相關公告。此次權益變動前,楊樹恆康持有公司8051.0018萬股股份,佔公司總股本的6.51%;此次權益變動後,楊樹恆康持股數量將變為4025.5009萬股,佔公司總股本的3.26%。截至公告日,此次協議轉讓尚未完成。
此次協議轉讓尚需深圳證券交易所合規性確認,並在中國證券登記結算有限責任公司深圳分公司辦理股份過户登記手續。
截至公告披露日,中山鬆德持有公司股份144,067,797股,佔公司總股本的11.66%,為公司持股5%以上股東。此次減持計劃時間已過半,中山鬆德在減持計劃期間尚未通過任何方式減持公司股份。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.